Performance of Long-wavelength Autofluorescence Imaging

Not Applicable

Completed

• Conditions: Retinal Disease; Retinal Degeneration; Retinal Dystrophies

• Registration Number: NCT03592017
• Lead Sponsor: Oxford University Hospitals NHS Trust

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-7-9
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 262

Inclusion Criteria

Inclusion Criteria:<br><br> - Age 18 years or above<br><br> - Defined retinal disease (patients) or no known retinal disease (healthy<br> participants)<br><br> - Participants willing to read and understand the study information and provide<br> informed consent<br><br> - Participants agree to have some examinations and photographs taken from their eyes<br><br>Exclusion Criteria:<br><br> - Significant opacities of the ocular media<br><br> - difficulties positioning still in front of the camera<br><br> - any ocular/ general disease known to affect recordings and/or analysis of retinal<br> images<br><br> - Pupil diameter <5mm

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Performance of long-wavelength autofluorescence imaging

Secondary Outcome Measures

Name	Time	Method
Optimization of the signal of long-wavelength autofluorescence imaging using different laser and filter settings;Quantification of the optimized signal of long-wavelength autofluorescence imaging in healthy controls and participants with various retinal diseases